Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) EPS (Basic) (2018 - 2025)

TransMedics has reported EPS (Basic) over the past 8 years, most recently at $3.1 for Q4 2025.

  • Quarterly results put EPS (Basic) at $3.1 for Q4 2025, up 1376.19% from a year ago — trailing twelve months through Dec 2025 was $5.6 (up 418.52% YoY), and the annual figure for FY2025 was $5.6, up 423.36%.
  • EPS (Basic) for Q4 2025 was $3.1 at TransMedics, up from $0.71 in the prior quarter.
  • Over the last five years, EPS (Basic) for TMDX hit a ceiling of $3.1 in Q4 2025 and a floor of -$0.78 in Q3 2023.
  • Median EPS (Basic) over the past 5 years was -$0.06 (2023), compared with a mean of $0.15.
  • Biggest five-year swings in EPS (Basic): plummeted 212.0% in 2023 and later skyrocketed 1376.19% in 2025.
  • TransMedics' EPS (Basic) stood at -$0.46 in 2021, then skyrocketed by 56.52% to -$0.2 in 2022, then soared by 160.0% to $0.12 in 2023, then skyrocketed by 75.0% to $0.21 in 2024, then skyrocketed by 1376.19% to $3.1 in 2025.
  • The last three reported values for EPS (Basic) were $3.1 (Q4 2025), $0.71 (Q3 2025), and $1.03 (Q2 2025) per Business Quant data.